RESET PHARMACEUTICALS
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. Its program focuses on psilocybin with psychotherapy for patients with cancer-related demoralization, anxiety, and depression.
RESET PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Website Url:
http://www.resetpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.12 M USD
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Montecito Bio Sciences, Ltd.
Bio-medical diagnostics company focused on the development and exploitation of a proprietary diagnostic and monitoring platform.
Official Site Inspections
http://www.resetpharma.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Reset Pharmaceuticals" on Search Engine
Press Release - Reset Pharma
Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health …See details»
Reset Pharmaceuticals Enters into Exclusive Worldwide
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma) a privately-held biotechnology company focused on developing and …See details»
Reset Pharmaceuticals - Crunchbase Company Profile & Funding
Also Known As Reset Pharmaceuticals, Inc. Company Type For Profit. Contact Email [email protected]. Reset Pharma is a biotechnology company that focuses on the …See details»
Reset Pharmaceuticals | LinkedIn
About us. Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life …See details»
UPDATE -- Reset Pharmaceuticals Enters into Exclusive …
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma) a privately-held biotechnology company focused on developing and …See details»
Reset Pharma Receives Notice of Safe to Proceed from FDA
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of …See details»
Reset Pharmaceuticals Enters into Exclusive Worldwide License …
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma) a privately-held biotechnology company focused on developing and …See details»
Reset Pharma Receives Notice of Safe to Proceed from FDA for ...
Nov 1, 2023 Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- …See details»
Reset Pharma Receives Notice of Safe to Proceed from FDA for ...
Nov 2, 2023 Reset Pharma is a privately held, clinical-stage biotechnology company focused on developing and commercializing novel treatments for patients suffering from …See details»
Reset Pharmaceuticals Appoints Innes Meldrum as President …
Jan 5, 2023 Reset Pharmaceuticals, Inc., a privately held biotechnology company focused on the development of innovative treatments to address mental health …See details»
Reset Pharma Receives Notice of Safe to Proceed from FDA for …
Nov 1, 2023 Reset Pharma is a privately held, clinical-stage biotechnology company focused on developing and commercializing novel treatments for patients suffering from …See details»
Reset Pharmaceuticals - Funding, Financials, Valuation & Investors
Reset Pharmaceuticals has raised a total of. $11.1M. in funding over 1 round. This was a Series A round raised on Feb 16, 2022. Reset Pharmaceuticals is funded by 3 …See details»
Reset Pharmaceuticals Appoints Innes Meldrum as President …
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of …See details»
2021 - Reset Pharma
Oct 14, 2021 Reset Pharmaceuticals, Inc. (Reset Pharma) announced today that Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board, will deliver a …See details»
Reset Pharmaceuticals announces appointment of neuroscience …
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and …See details»
Reset Pharmaceuticals - Updates, News, Events, Signals & Triggers
News • Jan 5, 2023. Globe Newswire — Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer. Funding Round • Feb 16, 2022. Reset …See details»
2022 - Reset Pharma
Nov 2, 2022 Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel …See details»
Cipher Pharmaceuticals Reports First Quarter 2024 Results
28 minutes ago Cipher Pharmaceuticals Reports First Quarter 2024 Results. Cipher Pharmaceuticals Inc. May 09, 2024, 17:00 ET. (All figures are presented in U.S. …See details»
Reset Pharmaceuticals - Crunchbase
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.See details»
Reset Pharma Receives Notice of Safe to Proceed from FDA for ...
New York, NY, November 1, 2023 – Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative …See details»